CQS
BNGO icon

Credential Qtrade Securities’s Bionano Genomics BNGO Stock Holding History

Credential Qtrade Securities’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$113 Hold
2
– – ﹤0.01% 374
2023
Q4 		$192 Hold
2
– – ﹤0.01% 368
2023
Q3 		$309 Hold
2
– – ﹤0.01% 338
2023
Q2 		$622 Hold
2
– – ﹤0.01% 367
2023
Q1 		$1.13K Hold
2
– – ﹤0.01% 384
2022
Q4 		$1.49K Buy
+2
New +$2.52K ﹤0.01% 325

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Credential Qtrade Securities's BNGO Position: Q1 2024 in Review

Credential Qtrade Securities held its Bionano Genomics (BNGO) position steady in Q1 2024 at 2 shares worth $113. The position accounts for ﹤0.01% of the portfolio, ranked #374.

Credential Qtrade Securities first reported a position in BNGO in Q4 2022 and has held it in 6 quarters since. The position peaked at $1.49K in Q4 2022. 55 funds tracked by Wall St. Rank hold BNGO as of Q1 2024.

  • Credential Qtrade Securities held 2 shares of Bionano Genomics worth $113 as of Q1 2024.
  • Credential Qtrade Securities left its Bionano Genomics share count unchanged in Q1 2024.
  • Bionano Genomics made up ﹤0.01% of Credential Qtrade Securities's portfolio in Q1 2024, its #374 holding.
  • Credential Qtrade Securities first reported a position in Bionano Genomics in Q4 2022 and has held it in 6 quarters since.
  • Credential Qtrade Securities's Bionano Genomics position peaked at $1.49K in Q4 2022.
  • 55 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2024.

Based on Credential Qtrade Securities's 13F filing for Q1 2024, filed 21 Jul 2025.